Crossref
Retraction Note: Hydroxyethylstarch as a Risk Factor for Acute Renal Failure
Drug Safety · 2026-09 · 49 (9) · 1111-1111
DOI: 10.1007/s40264-026-01701-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Safety, online erschienen am 09.07.2026. Verfasst von Joachim Boldt. Beteiligte Einrichtung: Department of Anaesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstr. 79, 67063, Ludwigshafen, Germany. BoldtJ@gmx.…. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Anaesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstr. 79, 67063, Ludwigshafen, Germany. BoldtJ@gmx.net.
Zitieren
APA
Boldt, J. (2026). Retraction Note: Hydroxyethylstarch as a Risk Factor for Acute Renal Failure. Drug Safety, 49(9), 1111-1111. https://doi.org/10.1007/s40264-026-01701-6
Vancouver
Boldt J. Retraction Note: Hydroxyethylstarch as a Risk Factor for Acute Renal Failure. Drug Safety. 2026;49(9):1111-1111. doi:10.1007/s40264-026-01701-6
BibTeX
@article{Boldt2026,
author = {Boldt, Joachim},
title = {Retraction Note: Hydroxyethylstarch as a Risk Factor for Acute Renal Failure},
journal = {Drug Safety},
year = {2026},
volume = {49},
number = {9},
pages = {1111--1111},
doi = {10.1007/s40264-026-01701-6}
}
EUVIMED